H S Richter - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

H S Richter

Showing results (21-30 of 39) with videos related to

Pageof 4

Sort By:

Journal of Experimental & Clinical Cancer Research : CR|October 16, 2021

Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesisOxana Schmidt, Nadja Nehls, Carolin Prexler, et al.

Cells|July 3, 2020

MHC Class I-Restricted TCR-Transgenic CD4<sup>+</sup> T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In VivoSebastian J Schober, Melanie Thiede, Hendrik Gassmann, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2012

High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patientsT G P Grunewald, A Ranft, I Esposito, et al.

Oncotarget|June 10, 2016

Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivoFranziska Blaeschke, Uwe Thiel, Andreas Kirschner, et al.

Cancers|February 5, 2020

Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing SarcomaGünther H S Richter, Tim Hensel, Oxana Schmidt, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 18, 2009

EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiationGünther H S Richter, Stephanie Plehm, Annette Fasan, et al.

Leukemia Research|July 4, 2012

MondoA is highly overexpressed in acute lymphoblastic leukemia cells and modulates their metabolism, differentiation and survivalCaroline M Wernicke, Günther H S Richter, Beate C Beinvogl, et al.

Cells|August 27, 2021

Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and FunctionHendrik Gassmann, Kira Schneider, Valentina Evdokimova, et al.

Frontiers in Medicine|January 23, 2026

Strengthening translational preclinical research through confirmatory multi-laboratory studiesSophia C Rotter, María Arroyo-Araujo, Natascha I Drude, et al.

Oncotarget|May 15, 2018

Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacyBushra Weidenbusch, Günther H S Richter, Marie Sophie Kesper, et al.

Pageof 4

Search research articles

Showing results (21-30 of 39) with videos related to

Sort By:

Pageof 4

Journal of Experimental & Clinical Cancer Research : CR|October 16, 2021

Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesisOxana Schmidt, Nadja Nehls, Carolin Prexler, et al.

Cells|July 3, 2020

MHC Class I-Restricted TCR-Transgenic CD4<sup>+</sup> T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In VivoSebastian J Schober, Melanie Thiede, Hendrik Gassmann, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2012

High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patientsT G P Grunewald, A Ranft, I Esposito, et al.

Oncotarget|June 10, 2016

Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivoFranziska Blaeschke, Uwe Thiel, Andreas Kirschner, et al.

Cancers|February 5, 2020

Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing SarcomaGünther H S Richter, Tim Hensel, Oxana Schmidt, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 18, 2009

EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiationGünther H S Richter, Stephanie Plehm, Annette Fasan, et al.

Leukemia Research|July 4, 2012

MondoA is highly overexpressed in acute lymphoblastic leukemia cells and modulates their metabolism, differentiation and survivalCaroline M Wernicke, Günther H S Richter, Beate C Beinvogl, et al.

Cells|August 27, 2021

Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and FunctionHendrik Gassmann, Kira Schneider, Valentina Evdokimova, et al.

Frontiers in Medicine|January 23, 2026

Strengthening translational preclinical research through confirmatory multi-laboratory studiesSophia C Rotter, María Arroyo-Araujo, Natascha I Drude, et al.

Oncotarget|May 15, 2018

Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacyBushra Weidenbusch, Günther H S Richter, Marie Sophie Kesper, et al.

Pageof 4